Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

267 results about "Protamine" patented technology

Protamines are small, arginine-rich, nuclear proteins that replace histones late in the haploid phase of spermatogenesis and are believed essential for sperm head condensation and DNA stabilization. They may allow for denser packaging of DNA in the spermatozoon than histones, but they must be decompressed before the genetic data can be used for protein synthesis. However, in humans and maybe other primates, 10-15% of the sperm's genome is packaged by histones thought to bind genes that are essential for early embryonic development.

Crystalline compositions for controlling blood glucose

The present invention relates to insulin crystals formed from zinc, protamine, a hexamer-stabilizing compound, and a polypeptide selected from the group consisting of insulin, an insulin analog, and a derivatized insulin. The crystals are suitable for administering to a patient for control of blood glucose levels. The crystals have been derived from the neutral protamine Hagedorn (NPH) form in a process utilizing precisely determined protamine concentrations and fortification of NPH crystals formed at a first lower concentration of protamine to achieve a second higher concentration of protamine.
Owner:BRADER MARK LAURENCE +2

Crystalline compositions for controlling blood glucose

InactiveUS20050054818A1Easily resuspendedPose of reactionPeptide/protein ingredientsImmunoglobulinsGlucose polymersD-Glucose
The present invention relates to a process for forming non-adsorbed insulin crystals from zinc, protamine, a hexamer-stabilizing compound, and a polypeptide selected from the group consisting of insulin, an insulin analog, a derivatized insulin, and a derivatized insulin analog. The crystals are suitable for administering to a patient for control of blood glucose levels. The crystals are formed in a process utilizing precisely determined protamine concentrations.
Owner:BRADER MARK LAURENCE +1

Point of care heparin determination system

Methods and devices for point of care determination of heparin concentration in blood are described. Cartridges including protamine ion sensitive electrodes (ISEs) and reference electrodes and systems for automatically determining heparin concentration in the cartridges are provided. Some systems add blood to a protamine bolus sufficient to bind all heparin, leaving excess protamine. The excess protamine concentration can be determined by measuring the initial slope of the electrode potential rate of change, and comparing the slope to known protamine concentration slope values In some cartridges, an oscillating pressure source moves the blood-protamine mixture back and forth across the protamine ISE. Some systems also use a second blood sample having the heparin removed or degraded to create a blank reference sample. Protamine ISEs can include polyurethane polymer, DNNS ionophore, and NPOE plasticizer. The polyurethane may include hard segments and soft segments, where both hard and soft segments may include cyclic and straight chain aliphatic moieties having essentially no ester or ether groups. Some hard segments may include methylene diphenyl groups. Some reference electrodes have the same polymer, plasticizer, and ionophore as the measurement electrode, but with a different concentration of ionophore.
Owner:MEDTRONIC INC

Antigen delivery compositions and methods of use

The present invention provides antigen delivery compositions and methods of using same to prevent or to treat cancers and other infectious diseases. More particularly, the present invention provides a lipid-protamine-DNA (LPD) vaccine delivery system and methods of using such LPD vaccine delivery system for the prevention and treatment of cancer and other infectious diseases.
Owner:PDS BIOTECH

Swelling granular mixed feed for adult pelteobagrus fulvidraco

The invention discloses a swelling granular mixed feed for adult pelteobagrus fulvidraco, relating to the field of pelteobagrus fulvidraco feed. The feed is suitable for feeding the pelteobagrus fulvidraco in adult stage (namely the pelteobagrus fulvidraco in the adult stage with the weight of more than 20g); the feed is a mixture prepared by all raw materials according to the processing method of swelling granular feeds; according to the weight percentage, the feed comprises the following raw materials of: 36-40% of fish meal, 15.58-19.6% of flour, 3.5-4% of cottonseed meal, 16-20% of soybean meal, 6-7% of maize protamine, 4.5-5.5% of fish oil, 6-7% of beer yeast, 1-1.5% of mineral matters, 0.5-0.6% of choline chloride and 0.2% of multivitamin. Compared with normal mixed feed, the swelling granular mixed feed has the advantages of comprehensive nutrition, high livability, little pollution on culture water, greenness, and no public nuisance.
Owner:福建天马饲料有限公司

Composition for gene delivery

Disclosed is a pharmaceutical composition for gene delivery, comprising: (i) a gene; (ii) a water-soluble chitosan; (iii) a thiamine pyrophosphate or a pharmaceutically acceptable salt thereof; (iv) a protamine or a pharmaceutically acceptable salt thereof; and (v) a neutral or anionic phospholipid. The composition can introduce a gene into cells safely and effectively. Composed of non-toxic and injectable components, the composition is safe for the body and can be advantageously commercialized. Notably, it can deliver a gene at high efficiency in vivo as well as in vitro, and is stable in the blood.
Owner:CHONG KUN DANG PHARMA CORP

Hemostatic system and components for extracorporeal circuit

A method and system for use in the course of extracorporeal blood flow, e.g., cardiopulmonary bypass, dialysis, and angioplasty procedures, in order to reduce or minimize inflammation, excessive bleeding, and other undesirable side effects. The system can include one or more automated blood parameter sensor modules and one or more blood parameter regulating modules. The system is particularly well suited to monitor and / or regulate blood parameters that include blood analytes (e.g., biomolecules, drugs or metabolites) as well as blood functions (e.g., clotting time, fibrinolytic activity, immune response). The system is particularly well suited for use in the management of clotting (e.g., heparing / protamine) and bleeding (e.g., aprotinin).
Owner:MEDTRONIC INC

Prophylactic or therapeutic composition for diabetes or obesity

Disclosed is a safe and non-toxic prophylactic or therapeutic composition for diabetes or obesity. The prophylactic or therapeutic composition for diabetes or obesity comprises as an active ingredient, a calcium receptor activator such as γ-Glu-X-Gly, wherein X represents an amino acid or an amino acid derivative; γ-Glu-Val-Y, wherein Y represents an amino acid or an amino acid derivative; γ-Glu-Ala; γ-Glu-Gly; γ-Glu-Cys; γ-Glu-Met; γ-Glu-Thr; γ-Glu-Val; γ-Glu-Orn; Asp-Gly; Cys-Gly; Cys-Met; Glu-Cys; Gly-Cys; Leu-Asp; γ-Glu-Met(O); γ-Glu-γ-Glu-Val; γ-Glu-Val-NH2; γ-Glu-Val-ol; γ-Glu-Ser; γ-Glu-Tau; γ-Glu-Cys(S-Me)(O); γ-Glu-Leu; γ-Glu-Ile; γ-Glu-t-Leu; γ-Glu-Cys(S-Me); cinacalcet; a cinacalcet analogue compound and protamine.
Owner:AJINOMOTO CO INC +1

Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA

Described herein are compositions and methods of use of targeted delivery complexes for delivery of siRNA to a disease-associated cell, tissue or pathogen. The targeted delivery complex comprises a targeting molecule, such as an antibody or fragment thereof, conjugated to one or more siRNA carriers. In preferred embodiments the siRNA carrier is a dendrimer or protamine and the targeting molecule is an anti-cancer antibody, such as hRS7. More preferably, the antibody or fragment is rapidly internalized into the target cell to facilitate uptake of the siRNA. Most preferably, the targeted delivery complex is made by the DNL technique. The compositions and methods are of use to treat a variety of disease states, such as cancer, autoimmune disease, immune dysfunction, cardiac disease, neurologic disease, inflammatory disease or infectious disease.
Owner:IBC PHARMACEUTICALS INC

Aptamer-based targeted delivery microRNA nanometer carrier as well as preparation method and application thereof

The invention relates to an aptamer-based targeted delivery microRNA nanometer carrier as well as a preparation method and application thereof. A targeting molecule is a sulfydryl-modified MUC-1molecule, and can be combined with cancer-inhibiting microRNA-34a, so that a MicroRNA-nanodiamond-protamine complex (MNPs) becomes AMNPs with an active targeting function; through electrostatic interaction, a negatively-charged aptamer-microRNA (Apt-miR) chimera is adsorbed to a cationic protamine-nanodiamond carrier to form a trinary compound carrier. The therapeutic effect of a nanotransport system on a non-small cell lung cancer is researched; the Apt-miR chimera is low in immunogenicity; the modified MUC-1 aptamer has high chemical stability in vivo, and can be chemically synthesized easily; in order to improve the transfection efficiency, a protamine-modified nanodiamond material (NPs) is used for helping miRNA to increase accumulation in a tumor part through permeability and retention enhancing effects.
Owner:BEIJING UNIV OF TECH

Reversible electrochemical sensors for polyions

The present invention is directed to a reversible electrochemical sensor for polyions. The sensor uses active extraction and ion stripping, which are controlled electrochemically. Spontaneous polyion extraction is suppressed by using membranes containing highly lipophilic electrolytes that possess no ion-exchange properties. Reversible extraction of polyions is induced by constant current pulse of fixed duration applied across the membrane. Subsequently, polyions are removed by applying a constant stripping potential. The sensors provide excellent stability and reversibility and allow for measurements of heparin concentration in whole blood samples via protamine titration.
Owner:AUBURN UNIV

Protamine fragment compositions and methods of use

Provided are bioactive, low-toxicity protamine fragments, compositions, combinations, kits and methods of using these components in a variety of embodiments, including neutralizing heparin and reducing post-operative bleeding. Improved protamine fragment-insulin solutions and methods for treating diabetes are also provided.
Owner:YANG VICTOR C +1

Preparation of protamine gold nanoclusters and application in analogue enzyme color comparison and fluorescence detection

The invention relates to preparation of protamine gold nanoclusters and application in analogue enzyme color comparison and fluorescence detection. The protamine gold nanoclusters not only have activity of horseradish peroxidase and oxidase, but also have fluorescent characteristic. Hereby, a protamine gold nanocluster analogue enzyme visual color comparator and a fluorescence sensor are established respectively and are used for detecting heavy metal ions. The protamine gold nanoclusters are prepared simply and conveniently, are low in cost, and have excellent fluorescence stability and chemical stability, and the shortcomings that fluorescence of traditional dyestuff is short in service life, photobleaching occurs easily and the like can be overcome; a fluorescence method is high in sensitivity and good in stability, and expensive instruments are not required; and analogue enzyme catalytic color comparison is sensitive and environment-friendly, and can be used for field real-time monitoring. The protamine gold nanoclusters are expected to be expanded and applied to detection and analysis of related substances in the fields of environment and biomedicines and disease markers, and have wide application prospect.
Owner:NANHUA UNIV

Method for detecting heparins

The invention relates to detection of heparins, in particular to a quick, accurate and sensitive method for detecting heparins. The method comprises the following steps of: testing potential changes caused by adding of heparins of different concentrations by using a potential tester according to specific combination of protamine in a polymer sensitive film phase and heparins in a water phase; drawing a standard work curve according to an initial potential change rate; and obtaining the concentration of heparins in an unknown sample in reference to the standard work curve. In the invention, protamine is added into a polymer film, so that the protamine is not required to be added manually; and an electrode can be directly applied to sample detection without activating, so that the method has the advantages of easiness and convenience for operating, short detection time, low operating cost, suitability for field detection, and the like.
Owner:YANTAI INST OF COASTAL ZONE RES CHINESE ACAD OF SCI

Method for separating purified protamine using reverse micelle method

The invention belongs to the technical field of separation and purification of bio-active substances, more particularly relates to a method for directly separating and purifying the protamine from crude protamine extract with a reverse micelle method. The invention aims at solving the problems of complex process, multiple steps and long cycle of present protamine purification. The invention directly separates, purifies the protamine from the crude protamine extract by adopting the reverse micelle solution which consists of a surfactant and an organic solvent and can realize the high-efficient extraction and back extraction of the protamine by adjusting the conditions of extraction processes such as pH of water phases, ionic strength, phase ratio, contact time of two phases; the highest enzyme recovery rate can reach more than 96 percent and the purification factor reaches more than 2.1. The process has the effects of both concentration and decoloration. In addition, the separation and purification of the protamine with the reverse protamine technology have the advantages of short cycle, convenient continuous operation and being easily amplified.
Owner:HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY

Insulin analogue having quick response and stability under acidic condition and preparation thereof

The invention relates to an isulin analogue having quick response and stability under acidic condition, and a medicinal composition and a medicinal preparation thereof. Asparagine (Asn) at the A 21 position of the chain A of the isulin analogue is mutated into glycine (Gly), the isulin analogue can be mixed with a long-acting isulin analogue such as insulin glargine to form a premixed preparationwith two functions of quick-acting sugar reduction and stable long-acting sugar reduction, and the problems that the conventional natural insulin (of pigs, cows and human) and quick-acting isulin analogues are unstable in the acidic environment, and the conventional isulin premixed preparation is not clarified and needed to be introduced with a foreign protein (such as protamine) serving as a slow release preparation so as to easily cause immune reaction, and is needed to be injected twice each day, namely in the morning and evening are solved, so that the safety of the preparation is higher.
Owner:GAN&LEE PHARMA

Oral insulin compound medicine preparation and its preparing method

The invention discloses an oral insulin complexing preparation, which is characterized by the following: allocating 1-15% insulin raw material, 50-97% stable protecting agent, 1-15% carrying medicine carrier, 1-20% absorption promoting agent; setting the stable protecting agent as one or several of carbowax and casein, protamine, albumin and protease inhibitor; setting the carrying medicine carrier as calcium phosphate salt; setting the absorption promoting agent as one or several of salicylic acid, cholate and fatty acid; setting the insulin raw material as human retooling insulin or human retooling insulin chemical trimmed by single methoxy carbowax derivant. This invention also relates to a preparing method of oral insulin complexing preparation. This invention can increase biostability of human retooling insulin and can resist degradation of gastrointestinal tract enzyme.
Owner:TONGHUA GOLDEN-HORSE PHARM IND CO LTD

Process for making low-temperature vacuum fried anchovy

The invention discloses a process for making low-temperature vacuum fried anchovy. The invention effectively solves the problem that an anchovy product is hard in meat quality, insufficient in crisp degree and not easy to chew because the anchovy is easy to rot and deteriorate in a processing procedure. The process comprises the following steps of: (1) raw material preprocessing; (2) deodorization; (3) dipping; (4) baking at a low temperature; (5) freezing; (6) frying in vacuum; and (7) deoiling. In the dipping step of the process, additives composed of 30-35% of dehydrated celery powder, 2-5% of protamine, 20-30% of microcrystalline cellulose, 30-35% of methylcellulose, 2-5% of sodium hydrogen sulfite and 3-8% of vitamin C by weight percentage are added. The process provided by the invention is simple and practicable, convenient to operate and suitable for factorized production and application; the anchovy in the making process is unlikely to rot and deteriorate; and the low-temperature vacuum fried anchovy obtained through the process provided by the invention is less in fishy smell, good in color and luster, crisp in taste, low in oil content and low in nutrition loss.
Owner:ZHEJIANG MARINE DEV RES INST

Natural fresh-keeping antiseptic containing protamine

The invention discloses a natural fresh-keeping antiseptic containing protamine. The invention is characterized in that the antiseptic is prepared from the following raw materials by weight ratio: 0.3-0.5 parts of the protamine, 1-1.5 parts of carboxymethyl chitosan, 1.2-1.8 parts of tea polyphenol and 0.6-0.8 parts of oxalic acid. The antiseptic overcomes limitations that present natural antiseptic is difficult to effectively maintain freshness and prolong preservation time; through effective combination of the protamine with the tea polyphenol and the carboxymethyl chitosan, the antiseptic can both significantly prolong preservation time of food and improve freshness of preserved food, and the antiseptic is safe, reliable, and easy for large-scale promotion.
Owner:顾小燕

Swelling granular mixed feed for parr of yellow catfish

The invention discloses a swelling granular mixed feed for parr of pelteobagrus fulvidraco, relating to the field of pelteobagrus fulvidraco feed. The feed is suitable for feeding the pelteobagrus fulvidraco in parr stage (namely the pelteobagrus fulvidraco in the parr stage with the weight of 2-20g); the feed is a mixture prepared by all raw materials according to the processing method of swelling granular feeds; according to the weight percentage, the feed comprises the following raw materials of: 44-48% of fish meal, 15.05-19.55% of flour, 2-5% of cottonseed meal, 15-17% of soybean meal, 3.5-5% of maize protamine, 3.5-4.5% of fish oil, 5-6% of beer yeast, 1-1.2% of mineral matters, 0.5-0.6% of choline chloride and 0.2% of multivitamin. Compared with normal mixed feed, the swelling granular mixed feed has the advantages of comprehensive nutrition, high livability, little pollution on culture water, greenness, and no public nuisance.
Owner:福建天马饲料有限公司

Compound food preservative

The invention belongs to the technical field of food processing and particularly relates to a compound food preservative. The compound food preservative comprises the following components in parts by mass: 3-9 parts of protamine, 11-14 parts of propolis, 10-16 parts of a lotus leaf extract, 12-16 parts of chitosan, 4-10 parts of tea polyphenol, and 50-70 parts of water. The components, such as the protamine, the propolis, the lotus leaf extract, the chitosan, the tea polyphenol, the water, essential oil, D-sodium erythorbate and allicin, adopted by the compound food preservative can be widely applied to food and can play a role in keeping freshness and preventing corrosion; as the natural components, such as the protamine, the propolis and the lotus leaf extract, are taken as main components of the compound food preservative and include extracts of natural plants and natural animal sources, the health of consumers cannot be damaged seriously even though the consumers eat a large quantity of preservative, and the natural components have excellent preservative effect.
Owner:SICHUAN HUIQUAN CANNED FOOD

Safe food preservative

The invention belongs to the technical field of food processing, and particularly relates to safe food preservative. The safe food preservative comprises, by mass, 2-7 parts of gingko leaf extractives, 4-9 parts of lysozyme, 12-15 parts of chitosan, 3-7 parts of spice extractives, 4-10 parts of protamines and 80-100 parts of water. According to the safe food preservative, the main inhibiting objects are pseudomonades, micrococcus, bacilli, enterobacteriaceae, vibrios, halobacterium, mycete and the like, and the application range is wide in beverages, seasoning, cooked wheaten food, cakes, sausages, canned fruit, various melons and fruits, vegetables and the like.
Owner:SICHUAN HUIQUAN CANNED FOOD

Protamine-Adenoviral Vector Complexes and Methods of Use

Embodiments of the invention include methods and compositions including viral composition that have high transduction efficiencies in vivo, in vitro and ex vivo. The viral composition include a viral vector and a protamine molecule, wherein the viral vector includes a polynucleotide encoding a tumor suppressor gene. The methods of the invention include administering the viral composition to a patient or subject for treatment of disease, in particular cancer, that is characterized by a reduced vector-induced production of neutralizing antibodies and a decreased vector-induced toxicity as compared to delivery of viral vectors alone.
Owner:JI LIN +1

Point of care heparin determination system

Methods and devices for point of care determination of heparin concentration in blood are described. Cartridges including protamine ion sensitive electrodes (ISEs) and reference electrodes and systems for automatically determining heparin concentration in the cartridges are provided. Some systems add blood to a protamine bolus sufficient to bind all heparin, leaving excess protamine. The excess protamine concentration can be determined by measuring the initial slope of the electrode potential rate of change, and comparing the slope to known protamine concentration slope values In some cartridges, an oscillating pressure source moves the blood-protamine mixture back and forth across the protamine ISE. Some systems also use a second blood sample having the heparin removed or degraded to create a blank reference sample. Protamine ISEs can include polyurethane polymer, DNNS ionophore, and NPOE plasticizer. The polyurethane may include hard segments and soft segments, where both hard and soft segments may include cyclic and straight chain aliphatic moieties having essentially no ester or ether groups. Some hard segments may include methylene diphenyl groups. Some reference electrodes have the same polymer, plasticizer, and ionophore as the measurement electrode, but with a different concentration of ionophore.
Owner:MEDTRONIC INC

Silicon oxide and protamine microcapsule and preparation method thereof

The invention relates to a silicon oxide and protamine microcapsule and a preparation method thereof. The silicon oxide and protamine microcapsule is prepared by using a calcium carbonate particulate as a template and sodium silicate and protamine as raw materials, wherein the mass ration of the sodium silicate to the protamine is 1:1-7:1. The preparation method comprises the following steps: firstly preparing the calcium carbonate particulate with negative charges as the template; interacting the protamine with positive charges and the calcium carbonate particulate with negative charges and alternately absorbing to the template; inducing the forming of silicon oxide by using the biomineralizing function of the protamine when three to five double-layers are generated on the template; removing the inner core of the calcium carbonate by EDTA-2Na. The invention is gentle in reaction conditions during the preparation of the silicon oxide and protamine microcapsule. The prepared silicon oxide and protamine microcapsule has the advantages of gentle reaction condition, size controllability, good stability, and excellent repeatability.
Owner:TIANJIN UNIV

Soft-granule pseudosciaena crocea juvenile compound feed

InactiveCN102771677AImprove conversion rateImprove protein digestibilityAnimal feeding stuffFeed conversion ratioFish oil
The invention discloses soft-granule pseudosciaena crocea juvenile compound feed which comprises fish meal, pre-gelatinized starch, extruded soybean, fermented soybean meal, corn protamine, fish oil, beer yeast, mineral, monocalcium phosphate, choline chloride, vitamin complex and the like. Compared with the traditional feed, the pseudosciaena crocea juvenile compound feed disclosed by the invention has the advantages of comprehensive nutrition, little pollution to culture water and wide source of raw materials; and compared with the existing extruded granulated feed, the soft-granule compound feed has the advantages of high feed conversion rate, high digestion utilization rate and the like, and is convenient to produce and green and pollution-free.
Owner:FUJIAN TIANMA TECH GRP

Environment-friendly and non-toxic preservative for condiments and preparation method of preservative

The invention provides an environment-friendly and non-toxic preservative for condiments and a preparation method of the preservative and relates to the technical field of food additives. The preservative is prepared from the following raw materials: protamine, chitosan, a tea polyphenol extract, a Chinese herbal medicine extract, trans-cinnamic acid, agaro-oligosaccharides, bacteriocin, nisin, a spice extract, an acidulant, ethanol and water. The prepared preservative is environment-friendly, non-toxic and pure-natural, compounds a plant source, an animal source and a microorganism source, is non-toxic and harmless for a human body, cannot affect human health, can effectively prolong the shelf life of a hot sauce product and has very high sterilization and bacteriostasis capabilities.
Owner:HEXIAN COUNTY JILONGSHAN CONDIMENT

Milt DNA-NA, protamine extract and preparing method thereof

The invention discloses a protamine DNA-NA extract, a protamine protein extract and a preparation method thereof. The method is as follows: (1) take the fish testis, add water to wash it, drain the water, and obtain the raw material of the fish testis; (2) add 1 to 10 times the volume of water, and at a temperature of 37 to 58 ° C, add 0.1 to 1.2%, enzymatic hydrolysis for 30 to 300 minutes; (3) Concentrate the filtrate to 30 to 80%; (4) Adjust the pH to 6.0 to 8.0 and put it on a cation exchange resin column, collect the effluent, and combine the combined effluent and eluate (5) Use 1-5% sodium chloride solution to continue eluting the cation exchange resin until the effluent has no protein, and collect the eluate. The protamine extract and protamine DNA-NA extract have high yield and purity, can be obtained simultaneously, and do not use polluting and toxic substances.
Owner:SHANGHAI HUIWEN BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products